Insitro nabs $400m in Series C financing led by CPPIB

Insitro, a machine learning-driven drug discovery and development company, has raised $400 million in Series C financing.

15 March 2021•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles